Navigation Links
BioInformatics, LLC New Market Report - Genomics Technologies
Date:1/6/2011

ARLINGTON, Va., Jan. 6, 2011 /PRNewswire/ -- BioInformatics, LLC announces the release of their newest market report:

Genomic Technologies:  Market Insights for Life Science Suppliers (#10-005)This report is for life science suppliers who want to respond in a timely fashion to the rapidly changing market for genomic analysis products. In this study, BioInformatics LLC quantifies and characterizes the market for genetic analysis including those products used for genome-wide association studies (GWAS), copy number variation (CNV) analysis, genotyping and techniques such as microarrays, sequencing and real-time PCR.

Survey respondents indicate planned lab expenditures by vendor.  The following suppliers were provided as some of the choices in the survey: Agilent TechnologiesAffymetrixBeckman CoulterBD BiosciencesBioneerBio-RadBioTroveCepheidEppendorfGE HealthcareHelicos BioscienceIdaho Technology, Inc.IlluminaLi-Cor BiosciencesLife TechnologiesLuminexQiagenRoche Applied ScienceSequenomStratageneTechne"In this study, we look at genetic analysis in current life science laboratories, the techniques and applications used, satisfaction and unmet needs with respect to current product offerings, budgets and predicted growth and future needs among life scientists," states Tamara Zemlo, Ph.D., MPH, Vice President of Advisory Services.  Dr. Zemlo adds that, "The information presented in this report will provide life science suppliers with information they can use to better meet their customers' needs as the field of genetic analysis continues to expand in new directions."

To learn more about these reports, a complimentary Executive Summary is available at

http://www.gene2drug.com/index.php?page=reports&id=211

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry.  By leveraging our professional social network of more than 50,000 life scientists, we have supported more than 300 companies and provided insights that lead to better business decisions.  Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information contact:Mary FollinManager, Marketing/SalesBioInformatics, LLC2111 Wilson Blvd., Suite 250Arlington, VA  22201703.778.3080 x13 (phone)m.follin@gene2drug.com

http://www.gene2drug.com/
'/>"/>

SOURCE BioInformatics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts
2. BioInformatics, LLC Studies Effective Strategies for Scientific Publishing in a Web 2.0 World
3. BioInformatics, LLC New Report -- The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III
4. BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010
5. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
6. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
7. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
8. Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil
9. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
10. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
11. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... ... 23, 2016 , ... UAS LifeSciences, one of the leading ... UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing high ... its list of well-respected retailers. This list includes such fine stores as Whole ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016 On Monday, ... call to industry to share solutions for the Biometric ... U.S. Customs and Border Protection (CBP), explains that CBP ... are departing the United States , ... and to defeat imposters. Logo - ...
(Date:6/20/2016)... , June 20, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... the prisons involved, it has secured the final ... (DOC) facilities for Managed Access Systems (MAS) installed. ... additional facilities to be installed by October, 2016. ...
(Date:6/15/2016)... June 15, 2016 Transparency ... titled "Gesture Recognition Market by Application Market - Global Industry Analysis ... 2024". According to the report, the  global gesture recognition ... 2015 and is estimated to grow at a ... by 2024.  Increasing application of gesture ...
Breaking Biology News(10 mins):